STATEMENT OF BENEFICIAL OWNERSHIP

Company

ELITE PHARMACEUTICALS INC /NV/

Filed

August 27, 2002

Accession Number

0001125282-02-002610

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →